Background: Visceral bleeding caused by ruptured mycotic aneurysms, especially intracerebral hematoma, is a most serious complication. In such cases, not only surgical techniques but also a variety of modalities such as catheter-based technique is required to comprehensively treat a patient with hemorrhage-induced coagulopathy.Case Reports: We treated an infectious endocarditis (IE) patient with coagulopathy caused by ruptured multiple mycotic aneurysms who underwent endovascular embolization using n-butyl cyanoacrylate (NBCA) and successful surgical removal assisted with catheter-based hemostasis. We also reviewed published literatures about mycotic aneurysm treated using NBCA using PUBMED. Upon review of the existing literature, it was evident that there are only a very limited number of publications related to “infectious” or “mycotic aneurysm” treated using NBCA, and only three case references were retrieved. Conclusion: Catheter-based techniques using n-butyl-2-cyanoacrylate (NBCA) which has been used as a liquid embolic agents is effective for patients with hemorrhage-induced coagulopathy caused by ruptured mycotic aneurysms before surgical treatment.
Keywords: Craniotomy, endovascular treatment, infection, splenectomy, visceral infarction, mycotic aneurysm.
The Role of Small, Dense Low-Density-Lipoproteins in Non-Coronary Forms of Atherosclerosis
Vascular Disease Prevention Cardiovascular Imaging in Thromboembolic Risk Stratification for Atrial Fibrillation: Recent Patents and Current Practice
Recent Patents on Medical Imaging (Discontinued) Gauzoma in A Scleroderma Patient Following Open Heart Surgery: A Case Report
Current Rheumatology Reviews The Role of Endothelial Dysfunction in Aortic Aneurysms
Current Pharmaceutical Design Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update
Current Vascular Pharmacology Role of microRNAs in Vascular Remodeling
Current Molecular Medicine Drainage of Cerebral Abscesses Prior to Valve Replacement in Stable Patients with Acute Left-Sided Infective Endocarditis
CNS & Neurological Disorders - Drug Targets Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection
Current Pharmaceutical Design Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm
Current Drug Targets The Location of Vascular Flap is Related with Daily Activity Patterns in Non-traumatic Acute Aortic Syndrome in a Chinese Population
Current Signal Transduction Therapy Anti-Platelet Treatment of Middle-Sized Abdominal Aortic Aneurysms
Current Vascular Pharmacology Fluorescein Fluorescence Use in the Management of Intracranial Neoplastic and Vascular Lesions: A Review and Report of a New Technique
Current Drug Discovery Technologies Abdominal Aortic Aneurysm (AAA): Is There a Role for the Prevention and Therapy Using Antioxidants?
Current Drug Targets Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment Target
Infectious Disorders - Drug Targets Anticoagulation in Patients with Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry An Evidence-Based Review of Off-Label Uses of Polidocanol
Current Clinical Pharmacology MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets
Current Medicinal Chemistry Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis
Current Pharmaceutical Design Preoperative and Follow up Multi-Detector Row CT Angiography (MDCTA) in the Evaluation of Interrupted Aortic Arch (IAA)
Current Medical Imaging Osteoclastogenesis in Abdominal Aortic Aneurysms: A New Therapeutic Target
Current Drug Targets